STRYPTIDE
"STRYPTIDE" is a word mark owned by CDHL Cayman, filed at the USPTO on August 28, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since August 28, 2026
- Filed
- August 28, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50078093
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns STRYPTIDE
The owner and representative on file with the office.
Owner
CDHL Cayman
Grand Cayman, Cayman Islands
Representative
Susan B. Meyer
Gordon Rees Scully Mansukhani LLP
What the mark covers
The products and services STRYPTIDE is filed for, grouped by Nice class.
Oral peptide strips
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About STRYPTIDE
Who owns the trademark "STRYPTIDE"?
The USPTO trademark "STRYPTIDE" (application 50078093) is owned by CDHL Cayman.
What is the status of "STRYPTIDE"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull STRYPTIDE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a04da7-4cc8-7079-9bbf-462840312dd5
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a04da7-4cc8-7079-9bbf-462840312dd5",
"object": "trademark",
"mark_text": "STRYPTIDE",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50078093",
"filing_date": "2026-08-28",
"nice_classes": [
5
],
"owners": [
{
"name": "CDHL Cayman",
"entity_id": null
}
]
}